Clinical Trial Update: Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the safety and tolerability of fosamprenavir with or without ritonavir in combination with TRIZIVIR or COMBIVIR for HIV infection; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• COMBIVIR (Lamivudine and Zidovudine)
• Fosamprenavir (fosamprenavir)
• Ritonavir (Ritonavir)
• Trizivir

Snippet

Sponsor: GlaxoSmithKline | Conditions: HIV Infections | Phase 3 | Status: COMPLETED